BIT - announcement
R&D Tax Incentive
Biotron Limited (ASX: BIT) is pleased to announce that is has received an R&D Tax Incentive refund
of $753,026 for the 2018/19 financial year.
The R&D Tax Incentive is an Australian Government program under which companies receive cash
refunds for 43.5% of eligible expenditure on research and development.
The incentive refund results from expenditure on Biotron's antiviral drug development programs.
Biotron's Managing Director, Dr Michelle Miller commented: "Whilst Biotron is fully funded for its
current activities, this R&D cash rebate will strengthen the Company's cash position and support
commercialisation activities."
- Forums
- ASX - Day Trading
- Day trading pre-market open March 19
Day trading pre-market open March 19, page-90
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)